Positive CHMP opinion for Gilead’s Epclusa in HCV
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion onGilead’s Epclusa for the treatment of chronic hepatitis C virus (HCV).
Click on this link for more information.
